Compare CYTK & FSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CYTK | FSS |
|---|---|---|
| Founded | 1997 | 1901 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.3B | 6.9B |
| IPO Year | 2004 | 1994 |
| Metric | CYTK | FSS |
|---|---|---|
| Price | $69.99 | $117.26 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 17 | 4 |
| Target Price | $85.59 | ★ $127.33 |
| AVG Volume (30 Days) | ★ 1.5M | 338.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 0.48% |
| EPS Growth | 3.49 | ★ 36.72 |
| EPS | N/A | ★ 3.02 |
| Revenue | $13,368,000.00 | ★ $1,861,500,000.00 |
| Revenue This Year | $341.94 | $15.50 |
| Revenue Next Year | $48.30 | $15.95 |
| P/E Ratio | ★ N/A | $38.33 |
| Revenue Growth | N/A | ★ 8.06 |
| 52 Week Low | $29.31 | $66.47 |
| 52 Week High | $70.98 | $132.89 |
| Indicator | CYTK | FSS |
|---|---|---|
| Relative Strength Index (RSI) | 56.80 | 54.92 |
| Support Level | $59.23 | $115.67 |
| Resistance Level | $67.75 | $120.28 |
| Average True Range (ATR) | 2.38 | 3.14 |
| MACD | 0.33 | 0.07 |
| Stochastic Oscillator | 79.93 | 60.04 |
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
Federal Signal Corp designs and manufactures products and integrated solutions for municipal, governmental, industrial, and airport customers. It operates in the segments of Environmental Solutions Group and the Safety and Security Systems Group. The Environmental Solutions group manufactures and supplies street sweeper vehicles, sewer cleaner and vacuum loader trucks, hydro-excavation trucks, high-performance water blasting equipment, dump truck bodies, and trailers. The Safety and Security Systems Group offers comprehensive systems and products such as campus and community alerting, emergency vehicles, first responder interoperable communications, and others. The company generates a majority of its revenue from the Environmental Solutions Group segment.